The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
Open accessAbstract
We recently reported the positional cloning of a candidate gene for hereditary hemochromatosis called HFE . The gene product, a member of the major histocompatibility complex class I-like family, was found to have a mutation, Cys-282 → Tyr (C282Y), in 85% of patient chromosomes. This mutation eliminates the ability of HFE to associate with β 2 -microglobulin (β 2 m) and prevents cell-surface expression. A second mutation that has no effect on β 2 m association, H63D, was found in eight out of nine patients heterozygous for the C282Y mutant. In this report, we demonstrate in cultured 293 cells overexpressing wild-type or mutant HFE proteins that both the wild-type and H63D HFE proteins form stable complexes with the transferrin receptor (TfR). The C282Y mutation nearly completely prevents the association of the mutant HFE protein with the TfR. Studies on cell-associated transferrin at 37°C suggest that the overexpressed wild-type HFE protein decreases the affinity of the TfR for transferrin. The overexpressed H63D protein does not have this effect, providing the first direct evidence for a functional consequence of the H63D mutation. Addition of soluble wild-type HFE/β 2 m heterodimers to cultured cells also decreased the apparent affinity of the TfR for its ligand under steady-state conditions, both in 293 cells and in HeLa cells. Furthermore, at 4°C, the added soluble complex of HFE/β 2 m inhibited binding of transferrin to HeLa cell TfR in a concentration-dependent manner. Scatchard plots of these data indicate that the added heterodimer substantially reduced the affinity of TfR for transferrin. These results establish a molecular link between HFE and a key protein involved in iron transport, the TfR, and raise the possibility that alterations in this regulatory mechanism may play a role in the pathogenesis of hereditary hemochromatosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disruption of the disulfide bridge results in decreased binding affinity for both β2-microglobulin and TfR (84).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Self-citationStructure of the human class I histocompatibility antigen, HLA-A2
Björkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,488
Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors
Edwards, C. Q., Griffen, L. M., Goldgar, D. E., Drummond, C., Skolnick, M. H., & Kushner, J. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182103 · Cited by 628
Receptor-mediated endocytosis of transferrin in K562 cells.
Klausner, R. D., van Renswoude, J., Ashwell, G., Kempf, C., Schechter, A. N., Dean, A., & Bridges, K. R. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32481-5 · Cited by 563
Karin, M., & Mintz, B. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69597-9 · Cited by 491
Feder, J. N., Tsuchihashi, Z., Irrinki, A., Lee, V. K., Mapa, F. A., Morikang, E., Prass, C. E., Starnes, S. M., Wolff, R. K., Parkkila, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14025 · Cited by 471
Self-citationJazwinska, E. C., Cullen, L. M., Busfield, F., Pyper, W. R., Webb, S. I., Powell, L. W., Morris, C. P., & Walsh, T. P. (1996) · Nature Genetics · doi:10.1038/ng1196-249 · Cited by 419
Mutation Analysis in Hereditary Hemochromatosis
Beutler, E., Gelbart, T., West, C., Lee, P. L., Adams, M., Blackstone, R., Pockros, P. J., Kosty, M. P., Venditti, C. P., Phatak, P. D., et al. (1996) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1996.0027 · Cited by 414
Hepatology: A Textbook of Liver Disease
O'Grady, J. (1997) · Gut · doi:10.1136/gut.40.4.562 · Cited by 387
Waheed, A., Parkkila, S., Zhou, X. Y., Tomatsu, S., Tsuchihashi, Z., Feder, J. N., Schatzman, R. C., Britton, R. S., Bacon, B. R., & Sly, W. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12384 · Cited by 380
Self-citationJouanolle, A. M., Gandon, G., Jézéquel, P., Blayau, M., Campion, M. L., Yaouanq, J., Mosser, J., Fergelot, P., Chauvel, B., Bouric, P., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-251 · Cited by 338
Biosynthesis of the human transferrin receptor in cultured cells.
Omary, M. B., & Trowbridge, I. S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42979-1 · Cited by 306
Parkkila, S., Waheed, A., Britton, R. S., Feder, J. N., Tsuchihashi, Z., Schatzman, R. C., Bacon, B. R., & Sly, W. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2534 · Cited by 251
Self-citationIsolation and characterization of the transferrin receptor from human placenta.
Seligman, P. A., Schleicher, R., & Allen, R. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86649-8 · Cited by 218
Regulation of HeLa cell transferrin receptors.
Ward, J. H., Kushner, J. P., & Kaplan, J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34022-5 · Cited by 182
Dadone, M. M., Kushner, J. P., Edwards, C. Q., Bishop, D. T., & Skolnick, M. H. (1982) · American Journal of Clinical Pathology · doi:10.1093/ajcp/78.2.196 · Cited by 178
Wada, H., Hass, P. E., & Sussman, H. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86360-3 · Cited by 174
Transferrin receptors in the human gastrointestinal tract
Banerjee, D., Flanagan, P. R., Cluett, J., & VALBERG, L. S. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90687-6 · Cited by 142
The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides
Fahnestock, M. L., Johnson, J. L., Feldman, R. M. R., Neveu, J. M., Lane, W. S., & Björkman, P. J. (1995) · Immunity · doi:10.1016/1074-7613(95)90129-9 · Cited by 141
Thermal Stability Comparison of Purified Empty and Peptide-Filled Forms of a Class I MHC Molecule
Fahnestock, M. L., Tamir, I., Narhi, L. O., & Björkman, P. J. (1992) · Science · doi:10.1126/science.1360705 · Cited by 128
Endocytosis and degradation mediated by the asialoglycoprotein receptor in isolated rat hepatocytes.
Weigel, P. H., & Oka, J. A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68175-5 · Cited by 124
Prevalence of heterozygotes for hemochromatosis in the white population of the United States
McLaren, C., Gordeuk, V., Looker, A., Hasselblad, V., Edwards, C., Griffen, L. M., Kushner, J. P., & Brittenham, G. (1995) · Blood · doi:10.1182/blood.v86.5.2021.bloodjournal8652021 · Cited by 92
Transferrin receptor distribution and regulation in the rat small intestine
Anderson, G. J., Powell, L. W., & Halliday, J. W. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90276-7 · Cited by 79
Parham, P., Androlewicz, M. J., Holmes, N. J., & Rothenberg, B. E. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32389-5 · Cited by 68
Transferrin Uptake by Cultured Rat Embryo Fibroblasts
Octave, J., Schneider, Y., Hoffmann, P., Trouet, A., & Crichton, R. R. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb19758.x · Cited by 59
Mulford, C., & Lodish, H. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60738-0 · Cited by 25
Extended repertoire of permissible peptide ligands for HLA‐B*2702
Raghavan, M., Lebrón, J. A., Johnson, J. L., & Björkman, P. J. (1996) · Protein Science · doi:10.1002/pro.5560051014 · Cited by 16
Self-citation
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- T H Bothwell, R W Charlton, A G Motulsky The Metabolic and Molecular Basis of Inherited Disease, eds C R Scriver, A L Beaudet, W S Sly, D Valle (McGraw-Hill, New York), pp. 2237–2269 (1995).
- C R Bebbingtion, C G G Hentschel DNA Cloning: A Practical Approach., ed D M Glover (IRL, Oxford), pp. 163–188 (1987).
Cited by
Sorted by citations
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Concerted and Birth-and-Death Evolution of Multigene Families
Nei, M., & Rooney, A. P. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.073003.112240 · Cited by 1,298
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,035
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Metadata
- Authors
- Feder, J. N., Penny, D. M., Irrinki, A., Lee, V. K., Lebrón, J. A., Watson, N., Tsuchihashi, Z., Sigal, E., Bjorkman, P. J., & Schatzman, R. C.
- Affiliations
- California Institute of Technology (US)
- Progenitor, Inc. (formerly Mercator Genetics, Inc.), 4040 Campbell Avenue, Menlo Park, CA 94025; and Division of Biology 156-29 and Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-02-17
- Volume
- 95
- Issue
- 4
- Pages
- 1472-1477
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19050
- OpenAlex
- W2141937988
- Cited by
- 827
- References
- 28
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 14 · 2019: 7 · 2018: 10 · 2017: 16 · 2016: 24 · 2015: 21 · 2014: 18 · 2013: 28 · 2012: 26
- FWCI
- 51.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- hereditary hemochromatosis, HFE gene, transferrin receptor, C282Y mutation, H63D mutation, beta2-microglobulin, protein complex formation, iron transport, pathogenesis
- MeSH terms
- Hemochromatosis Protein, Amino Acid Sequence, beta 2-Microglobulin, Hemochromatosis, HLA Antigens, Humans, Ligands, Membrane Proteins, Precipitin Tests, Protein Binding, Receptors, Transferrin, Structure-Activity Relationship, Transfection, Transferrin, Histocompatibility Antigens Class I, Point Mutation, Dimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review